Related Experiment Video
Updated: Oct 4, 2025
09:49
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
3.5K
Approach to the Patient With Lipodystrophy.
Lindsay T Fourman1, Steven K Grinspoon1
1Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
The Journal of Clinical Endocrinology and Metabolism
|February 9, 2022
Summary
Lipodystrophy, a rare fat absence disorder, causes severe metabolic issues. Recognizing lipodystrophy aids early screening and targeted treatments for better patient outcomes.
Area of Science:
- Endocrinology and Metabolism
- Genetics
- Rare Diseases
Background:
- Lipodystrophy is a group of rare diseases defined by the absence of adipose tissue.
- Healthy adipose tissue is crucial for metabolic homeostasis.
- Fat deficiency leads to metabolic disturbances like insulin resistance and hypertriglyceridemia.
Observation:
- Recent genetic studies suggest lipodystrophy is underdiagnosed.
- Patients experience profound metabolic disturbances and ectopic fat accumulation.
- The condition affects metabolic homeostasis, leading to insulin resistance and hypertriglyceridemia.
Findings:
- This article reviews the etiology and management of generalized and partial lipodystrophy.
- It synthesizes current scientific evidence and clinical guidelines.
- Key knowledge gaps in lipodystrophy research are highlighted.
Implications:
- Improved recognition of lipodystrophy enables timely screening for associated abnormalities.
- Targeted interventions can improve patient outcomes.
- Studying lipodystrophy offers insights into common obesity and adipose tissue disorders.
Related Concept Videos
01:24Overview of Lipid Metabolism
2.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.9K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
6
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
6